Ira Shoulson
Credentials: · ·
History
- 1975–1979
Neurology
Research
Levodopa and the progression of Parkinson's disease
New England Journal of Medicine · 2004 · 1,358 citations
Neurology · 1990 · 1,125 citations
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
Archives of Neurology · 2002 · 734 citations
35 papers
- RK
32 papers · 5 as a resident
22 papers
- SF
22 papers
- KM
19 papers
- BR
17 papers
- AY
16 papers
16 papers
Grants
- 2011–2018
Georgetown University Center of Excellence in Regulatory Science and Innovation (CERSI)
Food and Drug Administration · U01
Contact PI · $3.8M · Georgetown University
- 2002–2012
Prospective Huntington At Risk Observational Study (PHAROS)
National Human Genome Research Institute · R01
Contact PI · $7.6M · University of Rochester
- 1987–1995
Deprenyl/Tocopherol Antioxidative Therapy of Parkinson's
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $16.3M · University of Rochester
- 1982–1990
Baclofen as Protective Therapy in Huntington's Disease
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $549.2K · University of Rochester
Clinical trials
- 2008–2011
Effects of Coenzyme Q10 (CoQ) in Parkinson Disease
Principal investigator · Terminated · Phase 3
Weill Medical College of Cornell University
- 2006–2020
Cooperative Huntington's Observational Research Trial
Principal investigator · Unknown
HP Therapeutics Foundation
- 2005–2007
TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Principal investigator · Completed · Phase 3
Amarin Neuroscience Ltd
- 2000–2003
Principal investigator · Completed · Phase 3
Teva Branded Pharmaceutical Products R&D, Inc.